Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus

被引：0
|
作者：
A K Hemanth Kumar
V Chandrasekaran
T Kannan
A Lakshmi Murali
J Lavanya
V Sudha
Soumya Swaminathan
Geetha Ramachandran
机构：
[1] National Institute for Research in Tuberculosis,Department of Biochemistry and Clinical Pharmacology
[2] State TB Officer,undefined
[3] District TB Officer,undefined
来源：
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词：
Tuberculosis; Anti-tuberculosis drug concentrations; Revised National Tuberculosis Control Programme; Diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 70
页数：5
相关论文
共 50 条
  • [41] Optimized anti-tuberculosis duration for drug-susceptible pulmonary tuberculosis-diabetes mellitus comorbidities: study protocol for a multicenter randomized controlled trial
    Peize Zhang
    Huaifang Shi
    Yongping Xie
    Jiemei Liang
    Qiumeng Hu
    Liang Fu
    Yuxiang Wang
    Jie Tan
    Senlin Zhan
    Hongjuan Qin
    Guanghui Xu
    Guofang Deng
    BMC Pulmonary Medicine, 24 (1)
  • [42] Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus
    Ichikawa, Chikako
    Tanaka, Sho
    Takubo, Masahiro
    Kushimoto, Masaru
    Ikeda, Jin
    Ogawa, Katsuhiko
    Tsujino, Ichiro
    Suzuki, Yutaka
    Abe, Masanori
    Ishihara, Hisamitsu
    Fujishiro, Midori
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 463 - 470
  • [43] Anti-tuberculosis drug development via targeting the cell envelope of Mycobacterium tuberculosis
    Xu, Xinyue
    Dong, Baoyu
    Peng, Lijun
    Gao, Chao
    He, Zhiqun
    Wang, Chuan
    Zeng, Jumei
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [44] ANTI-TUBERCULOSIS CHEMOTHERAPY
    JOHNSTON, RF
    AUDET, PR
    AMERICAN FAMILY PHYSICIAN, 1978, 17 (06) : 136 - 139
  • [45] Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay
    Patrick Fitzwater, Sean
    Andrew Sechler, G.
    Jave, Oswaldo
    Coronel, Jorge
    Mendoza, Alberto
    Gilman, Robert H.
    Friedland, Jon S.
    Moore, David A. J.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (05) : 1163 - 1171
  • [46] Assessing the Effect of the Anti-tuberculosis Drug Rifampicin on Known Hypertensive Patients With Tuberculosis in a Tertiary Care Center
    Yogesh, S.
    Nallathambi, Naveenkumar
    Raja, K. Ganapathy
    Seshadri, Hariharan
    Gautham, R.
    Naidu, Shriganesh P.
    Navvin, S.
    Ezhilarasu, Preetham
    Ahimth, Ja
    Srinivasan, Suriya Prakash
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [47] Evaluation of Tuberculosis Underreporting in Greece through Comparison with Anti-Tuberculosis Drug Consumption
    Lytras, Theodore
    Spala, Georgia
    Bonovas, Stefanos
    Panagiotopoulos, Takis
    PLOS ONE, 2012, 7 (11):
  • [48] Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia
    Molla, Yalew
    Wubetu, Muluken
    Dessie, Bekalu
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2021, 13 : 1 - 8
  • [49] Patients with secondary amenorrhea due to tuberculosis endometritis towards the induced anti-tuberculosis drug category 1
    Perdhana, Raditya
    Sutrisno, Sutrisno
    Sugiri, Yani Jane
    Baktiyani, Siti Candra Windu
    Wiyasa, Arsana
    PAN AFRICAN MEDICAL JOURNAL, 2016, 24
  • [50] ANTI-TUBERCULOSIS VACCINES
    RANGANATHAN, KS
    BRITISH MEDICAL JOURNAL, 1959, 2 (NOV21): : 1101 - 1101
12345